An Update on Src Family of Nonreceptor Tyrosine Kinases Biology

J Espada1, J Martín-Pérez2

  • 1Experimental Dermatology and Skin Biology Group, Ramón y Cajal Institute for Health Research (IRYCIS), Ramón y Cajal University Hospital, Colmenar Viejo Rd. Km 9,100, 28034 Madrid, Spain; Bionanotechnology Lab, Universidad Bernardo O´Higgins, General Gana 1780, 8370854 Santiago, Chile.

Insights

Src family kinases (SFKs) regulate cell functions and are vital in development and tissue maintenance. This review updates SFK regulation, including redox pathways, and their roles in prolactin signaling, breast cancer, and stem cell biology.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Src family kinases (SFKs) are crucial nonreceptor tyrosine kinases involved in diverse cellular processes like proliferation, migration, differentiation, and survival.
  • SFKs integrate signals from various receptors, including growth factors, hormones, and adhesion proteins, contributing to complex cellular signaling networks.
  • Dysregulation of SFKs is linked to various pathologies, notably cancer, highlighting their importance in health and disease.

Purpose of the Study:

  • To provide an updated overview of the major regulatory mechanisms governing SFK activity.
  • To explore the emerging role of redox-dependent pathways in SFK regulation.
  • To examine the functional implications of SFKs in prolactin signaling, breast cancer development, and stem cell regulation.

Main Methods:

  • Literature review and synthesis of existing research on SFK regulation and function.
  • Analysis of studies investigating SFK involvement in specific signaling pathways (e.g., prolactin signaling).
  • Review of research on SFK roles in embryonic, somatic, and cancer stem cells.

Main Results:

  • SFKs are regulated by multiple mechanisms, with redox-dependent pathways emerging as a significant area of study.
  • SFKs play a critical role in prolactin signaling and are implicated in the development and progression of breast cancer.
  • SFKs are involved in the regulation of stem cell populations, including embryonic, somatic, and breast cancer stem cells.

Conclusions:

  • SFKs are central regulators of cellular functions, with their dysregulation contributing to diseases like cancer.
  • Understanding SFK regulation, particularly redox-dependent mechanisms, is crucial for therapeutic development.
  • SFKs have significant implications in stem cell biology and cancer, warranting further investigation.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.1K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.8K
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
6.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K